Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Commentary on: OpenUrl
Few patients with acute ischaemic stroke receive intravenous recombinant tissue plasminogen activator (rtPA), with the main exclusion criterion being hospital arrival after 4½ h.1 The second most common exclusion criterion from rtPA treatment, which is present in approximately 1/3 of all patients, is a mild or rapidly improving syndrome, termed ‘too good to treat’.2 Uncertainty remains as to whether these patients …
Competing interests None.